Literature DB >> 12618862

Linkage disequilibrium between the MBP tetranucleotide repeat and multiple sclerosis is restricted to a geographically defined subpopulation in Finland.

H Pihlaja1, T Rantamäki, J Wikström, M-L Sumelahti, M Laaksonen, J Ilonen, J Ruutiainen, T Pirttilä, I Elovaara, M Reunanen, S Kuokkanen, L Peltonen, K Koivisto, P J Tienari.   

Abstract

We have previously found evidence for linkage as well as allelic and haplotype association between the myelin basic protein (MBP) gene and multiple sclerosis (MS). These findings have, however, not been reproduced in other populations. Here, we have analyzed association between MBP and MS in a new set of 349 Finnish triad families. Families with a parent born in the Southern Ostrobothnian region in western Finland (Bothnia families, n=98) were analyzed as a separate group since our previous studies included a high proportion of patients and families from this high-incidence region. Other families (n=251) were collected at five hospitals in southern, eastern, and northern Finland. The MBP short tandem repeat was genotyped, and haplotype patterns were verified by sequencing. In the Bothnia families, the previously detected associations with the 1.27 kb allele and haplotype 1.27-B10 were confirmed (P=0.01 and 0.02, respectively), whereas in the other families there was not even a trend toward association. These results demonstrate a geographic/genealogical restriction in the association between MS and the MBP short tandem repeat, highlight the importance of genealogical information in genetic studies of complex traits, and may provide an explanation why the association has not been found in many other populations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12618862     DOI: 10.1038/sj.gene.6363943

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  8 in total

1.  A follow-up study of chromosome 19q13 in multiple sclerosis susceptibility.

Authors:  Alessandro Bonetti; Keijo Koivisto; Tuula Pirttilä; Irina Elovaara; Mauri Reunanen; Mikko Laaksonen; Juhani Ruutiainen; Leena Peltonen; Terhi Rantamäki; Pentti J Tienari
Journal:  J Neuroimmunol       Date:  2009-02-04       Impact factor: 3.478

2.  Finding disease candidate genes by liquid association.

Authors:  Ker-Chau Li; Aarno Palotie; Shinsheng Yuan; Denis Bronnikov; Daniel Chen; Xuelian Wei; Oi-Wa Choi; Janna Saarela; Leena Peltonen
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

3.  Gene expression profiles in Finnish twins with multiple sclerosis.

Authors:  Silja Särkijärvi; Hanna Kuusisto; Raija Paalavuo; Mari Levula; Nina Airla; Terho Lehtimäki; Jaakko Kaprio; Markku Koskenvuo; Irina Elovaara
Journal:  BMC Med Genet       Date:  2006-02-27       Impact factor: 2.103

4.  Identity-by-descent mapping in a Scandinavian multiple sclerosis cohort.

Authors:  Helga Westerlind; Kerstin Imrell; Ryan Ramanujam; Kjell-Morten Myhr; Elisabeth Gulowsen Celius; Hanne F Harbo; Annette Bang Oturai; Anders Hamsten; Lars Alfredsson; Tomas Olsson; Ingrid Kockum; Timo Koski; Jan Hillert
Journal:  Eur J Hum Genet       Date:  2014-08-27       Impact factor: 4.246

5.  Comparison of antibodies hydrolyzing myelin basic protein from the cerebrospinal fluid and serum of patients with multiple sclerosis.

Authors:  Visilii B Doronin; Taisiya A Parkhomenko; Massimiliano Castellazzi; Marina Padroni; Michela Pastore; Valentina N Buneva; Enrico Granieri; Georgy A Nevinsky
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

6.  Changes in haematopoietic progenitor colony differentiation and proliferation and the production of different abzymes in EAE mice treated with DNA.

Authors:  Kseniya S Aulova; Ludmila B Toporkova; Julia A Lopatnikova; Alina A Alshevskaya; Sergei V Sennikov; Valentina N Buneva; Thomas Budde; Sven G Meuth; Nelly A Popova; Irina A Orlovskaya; Georgy A Nevinsky
Journal:  J Cell Mol Med       Date:  2017-08-05       Impact factor: 5.310

7.  DNA-hydrolysing activity of IgG antibodies from the sera of patients with schizophrenia.

Authors:  Evgeny A Ermakov; Ludmila P Smirnova; Taisiya A Parkhomenko; Pavel S Dmitrenok; Nina M Krotenko; Nikolai S Fattakhov; Nikolay A Bokhan; Arkadiy V Semke; Svetlana A Ivanova; Valentina N Buneva; Georgy A Nevinsky
Journal:  Open Biol       Date:  2015-09       Impact factor: 6.411

8.  Comparison of DNA-hydrolyzing antibodies from the cerebrospinal fluid and serum of patients with multiple sclerosis.

Authors:  Taisiya A Parkhomenko; Vasilii B Doronin; Massimiliano Castellazzi; Marina Padroni; Michela Pastore; Valentina N Buneva; Enrico Granieri; Georgy A Nevinsky
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.